Skip to content
Open access

Aβ42-Driven α-synuclein Fibril Polymorphism and Distinct Intracellular Aggregation

Sep 2026 · bioRxiv · 0 citations · 81 references
Biology Medicine

TL;DR

Heterotypic interactions with Aβ42 reshape α-syn aggregation pathways and fibril conformations, generating structurally distinct α-syn fibril populations with different neuronal seeding activities, which provide a molecular framework for understanding how cross-talk between amyloidogenic proteins may contribute to structural and pathological heterogeneity in mixed neurodegenerative diseases.

Read PDF

Similar papers

Open access

Aggregation, Propagation and Pathological Implications of α-synuclein Amyloid Fibrils in Parkinson’s Disease

It is shown that α-synuclein fibrils are more structurally heterogenous than previously believed and that they may continue to remodel their architecture over the course of PD, and fibril assembly pathways and resulting fibril structure are highlighted as critical targets for future therapeutic strategies.

Fritjof Havemeister · 0 citations
Aug 2026

Triprolidine Interferes with α-Synuclein Fibrillation and Remodels Aggregate Structure via Conformational Modulation.

Findings demonstrate that TC modulates both the structural dynamics and functional toxicity of α-synuclein, and highlight its potential as a promising chemical modulator for further investigation in PD-related protein aggregation.

Md Nadir Hassan, Murtaza Hussain, Faisal Nabi et al. · 0 citations
Aug 2026

Structural basis of α-synuclein and DJ-1 complex.

Based on the structure, a DJ-1-derived peptide (173-180) is designed that significantly inhibited α-synuclein aggregation in TEM and ELISA assays, suggesting its potential as a therapeutic candidate for α-synucleinopathies.

Hyeon Jin Kim, Da Hye Kim, Chang-Woo Han et al. · 0 citations
Open access Aug 2026

Targeted degradation of alpha-synuclein impedes PFF-induced aggregation

The Affinity-directed PROtein Missile system is employed and targeted degradation of α-synuclein impedes the pre-formed fibril (PFF)-induced aggregation of α-synuclein in primary neurons derived from rats expressing human α-synuclein.

Bill Carton, Géraldine Gelders, Gajanan Sathe et al. · 0 citations
Open access Aug 2026

Backbone Thioamide Substitution Enhances the Activity of Short Peptides in Modulating the Aggregation of α-Synuclein

The non-amyloid-β component (NAC) region of the Parkinson’s-associated protein α-synuclein plays a key role in its pathogenic aggregation, motivating the development of molecules that target this critical region. Here, we show that a minimal NAC-derived motif, 66VGGAVVT72, can be reprogrammed through backbone engineeri...

Haoliang Zheng, Kyren Miller, Magdalena I. Ivanova et al. · 0 citations
Open access Aug 2026

Hyphenated Mass Spectrometry-Based Strategies for Characterizing Oligomers of α‑Synuclein in Parkinson’s Disease

It is shown that oligomerization drives a transition from dynamic monomers to increasingly ordered intermediates, relevant to models in which α-syn oligomerization alters normal membrane engagement during PD-associated aggregation.

Raya Sadighi, Andrea Istrati, Sigourney Karijodikoro et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.